- Gaelic Laboratories unveils a new website detailing its modernized HPRA-licensed facilities.
- The company offers expanded Beta-Lactam manufacturing and testing services across multiple regions.
Gaelic Laboratories, a CDMO specialising in the manufacture of penicillin has launched a new website to showcase the capabilities of its modernised HPRA-licensed facilities in Ireland. The updated site highlights newly-equipped laboratories that provide rapid and cost-effective release testing.
Established in April 2022, Gaelic Laboratories is based in Clonmel, Ireland, on a site previously used by an FDA-approved Beta-Lactam manufacturer. The company offers testing and manufacturing services for Beta-Lactams to markets in the EU, UK, and MENA regions.
Brian Morrissey, General Manager of the Gaelic Laboratories site, remarked, “We’ve been very fortunate that the levels of investment received have allowed us to obtain and build on some pretty advanced technologies and competencies. We’ve managed to improve and expand our technology base to the most up-to-date standards.”
The company’s testing services cover microbiology, chemical, analytical, and environmental testing. This includes raw material testing, finished product and stability testing, route, process and cleaning validation and monitoring, quality control, and regulatory administration.
In addition to manufacturing a broad range of Beta-Lactam products, Gaelic Laboratories offers contract manufacturing and packaging services. The company is investing in expanding its workforce to over 100 employees at the Clonmel site, creating opportunities for skilled jobs in the STEM sector.
“We are going through an exciting period of growth, with opportunities for employment in our testing laboratories and at our manufacturing plant,” Morrissey added. “It’s great to be able to support the creation of highly-skilled jobs in Europe, contributing to the ‘Innovation Economy.”
Overview of outsourcing trends 
